Loading...

SYNLOGIC INC Investments/Divestments 8-K Filing

SYNL

SYNLOGIC INC

()

2023 8-K

Stock Delisting Notice

Stock Delisting Notice

Annual Meeting Results

Delisting Notice

Director Resignation

Director Resignation

Management Changes

Annual Meeting Results

Financial Results

Financial Results Announcement

Financial Results Announcement

Director Appointment and Re...

Financial Results Announcement

Departure of Directors

Shareholder Rights Plan

Restructuring and reorganis...

Amendment to Employment Agr...

Resignation of CFO

Stock Option Repricing

Earnings Report

Agreement for Stock Issuance

Reverse Stock Split

Special Meeting

Extension of Option Agreement

Earnings Reports

Amendment to Certificate of...

Workforce Reduction

Financial Results Announcement

Financial Results Announcement

FDA Designation

External Links:

Synlogic, Inc. extends the deadline for Roche to exercise an exclusive option right for the development of a Synthetic Biotic medicine for inflammatory bowel disease.

AI Assistant

SYNLOGIC INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.